Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer.

John P. Crown, Véronique Diéras, Elzbieta Staroslawska, Denise A. Yardley, Thomas Bachelot, Neville Davidson, Hans Wildiers, Peter A. Fasching, Olivier Capitain, Manuel Ramos, Richard Greil, Francesco Cognetti, George Fountzilas, Maria Blasinska-Morawiec, Cornelia Liedtke, Rolf Kreienberg, Wilson H. Miller, Vanessa Tassell, Xin Huang, Jolanda PaoliniKenneth A. Kern, Gilles Romieu

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer.'. Together they form a unique fingerprint.

Medicine & Life Sciences